Literature DB >> 8883936

Transient expression of the mitogen-activated protein kinase phosphatase MKP-1 (3CH134/ERP1) in the rat brain after limbic epilepsy.

P Gass1, A Eckhardt, H Schröder, R Bravo, T Herdegen.   

Abstract

The immediate early gene-encoded enzyme, MAP kinase phosphatase 1 (MKP-1), is thought to be a key element in controlling cellular signalling pathways activated by MAP kinases. Since MAP kinase have been demonstrated to participate in neuronal stimulus-transcription coupling following seizure activity, the present study investigated the induction of MKP-1 in the rat brain after limbic epilepsy. MKP-1 expression was studied with a polyclonal antiserum by Western blots, immunocytochemistry and immuno-electron microscopy at different time periods between 1 and 24 h after kainic acid-induced limbic seizures. MKP-1 induction was identified in dentate granule cells of the hippocampus but not in pyramidal neurons, furthermore in neurons of the outer layers of the neocortex, as well as in neurons of the lateral nucleus of the bed of the stria terminalis. Immuno-electron microscopy demonstrated that MKP-1 was localized in the neuronal nucleus, where the substrate of MKP-1, activated MAP kinases, are also found. In view of the restricted areas of MKP-1 expression and the widespread areas of altered MAP kinases activity it can be concluded that in the majority of CNS populations other mechanisms than MKP-1 induction are responsible for the shut-off of MAP kinases following seizure activity. MKP-1 may contribute in the specific subpopulations where it is induced to the post-translational control of inducible transcription factors of the fos, jun and myc family.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883936     DOI: 10.1016/0169-328x(96)00068-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  5 in total

1.  Mitogen-activated protein kinase phosphatase (MKP)-1 as a neuroprotective agent: promotion of the morphological development of midbrain dopaminergic neurons.

Authors:  Louise M Collins; Gerard W O'Keeffe; Caitriona M Long-Smith; Sean L Wyatt; Aideen M Sullivan; André Toulouse; Yvonne M Nolan
Journal:  Neuromolecular Med       Date:  2013-04-13       Impact factor: 3.843

2.  A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine.

Authors:  N Brehm; F Bez; T Carlsson; B Kern; S Gispert; G Auburger; M A Cenci
Journal:  Mol Neurobiol       Date:  2014-10-12       Impact factor: 5.590

3.  SRF modulates seizure occurrence, activity induced gene transcription and hippocampal circuit reorganization in the mouse pilocarpine epilepsy model.

Authors:  Pascal Lösing; Cristina Elena Niturad; Merle Harrer; Christopher Meyer Zu Reckendorf; Theresa Schatz; Daniela Sinske; Holger Lerche; Snezana Maljevic; Bernd Knöll
Journal:  Mol Brain       Date:  2017-07-17       Impact factor: 4.041

4.  Deficit of mitogen-activated protein kinase phosphatase 1 (DUSP1) accelerates progressive hearing loss.

Authors:  Isabel Sánchez-Pérez; Jose M Bermúdez-Muñoz; Adelaida M Celaya; Lourdes Rodríguez-de la Rosa; Laura Pintado-Berninches; Rosario Perona; Silvia Murillo-Cuesta; Isabel Varela-Nieto
Journal:  Elife       Date:  2019-04-02       Impact factor: 8.140

5.  MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer's disease models.

Authors:  Yehong Du; Yexiang Du; Yun Zhang; Zhilin Huang; Min Fu; Junjie Li; Yayan Pang; Peng Lei; Yu Tian Wang; Weihong Song; Guiqiong He; Zhifang Dong
Journal:  Signal Transduct Target Ther       Date:  2019-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.